Mechanisms of bone fragility in a mouse model of glucocorticoid-treated rheumatoid arthritis: Implications for insufficiency fracture risk

Arthritis and Rheumatism

Volumn 64, Issue 11, 2012, Pages 3649-3659

  Takahata, Masahiko ^a   Maher, Jason R ^a   Juneja, Subhash C ^a   Inzana, Jason ^a   Xing, Lianping ^a   Schwarz, Edward M ^a   Berger, Andrew J ^a   Awad, Hani A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE FRAGILITY; BONE METABOLISM; BONE STRENGTH; BONE STRUCTURE; CHEMICAL COMPOSITION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAPHYSIS; FRACTURE; HISTOPATHOLOGY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAMAN SPECTROMETRY; RHEUMATOID ARTHRITIS; RIGIDITY; TIBIA; TRABECULAR BONE;

ANIMALS; ARTHRITIS, RHEUMATOID; BIOMECHANICS; BONE REMODELING; DISEASE MODELS, ANIMAL; FRACTURES, BONE; GLUCOCORTICOIDS; HUMANS; MALE; MICE; MICE, TRANSGENIC; PREDNISOLONE; RISK FACTORS; SPECTRUM ANALYSIS, RAMAN; SPINE; TIBIA; TRANSGENES; TUMOR NECROSIS FACTOR-ALPHA; X-RAY MICROTOMOGRAPHY;

EID: 84868129753     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34639     Document Type: Article

References (51)

1. Angeli A, Guglielmi G, Dovio A, Capelli G, de Feo D, Giannini S, et al. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 2006; 39: 253-9.
2. Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton IL, et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004; 19: 893-9.
3. Nampei A, Hashimoto J, Koyanagi J, Ono T, Hashimoto H, Tsumaki N, et al. Characteristics of fracture and related factors in patients with rheumatoid arthritis. Mod Rheumatol 2008; 18: 170-6.
4. Goldring SR,. Inflammatory mediators as essential elements in bone remodeling. Calcif Tissue Int 2003; 73: 97-100.
5. Guo R, Yamashita M, Zhang Q, Zhou Q, Chen D, Reynolds DG, et al. Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins. J Biol Chem 2008; 283: 23084-92.
6. Kaneki H, Guo R, Chen D, Yao Z, Schwarz EM, Zhang YE, et al. Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. J Biol Chem 2006; 281: 4326-33.
7. Nanes MS,. Tumor necrosis factor-α: molecular and cellular mechanisms in skeletal pathology. Gene 2003; 321: 1-15.
8. Zhao L, Huang J, Zhang H, Wang Y, Matesic LE, Takahata M, et al. Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp1. Stem Cells 2011; 29: 1601-10.
9. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007; 13: 156-63.
10. Pennisi P, Trombetti A, Rizzoli R,. Glucocorticoid-induced osteoporosis and its treatment. Clin Orthop Relat Res 2006; 443: 39-47.
11. Goldring SR, Goldring MB,. Rheumatoid arthritis and other inflammatory joint pathologies. In:, Seibel MJ, Robins SP, Bilezikian JP, editors. Dynamics of bone and cartilage metabolism. Burlington (MA): Academic Press; 2006. p. 843-69.
12. Li P, Schwarz EM,. The TNF-α transgenic mouse model of inflammatory arthritis. Springer Semin Immunopathol 2003; 25: 19-33.
13. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991; 10: 4025-31.
14. Proulx ST, Kwok E, You Z, Beck CA, Shealy DJ, Ritchlin CT, et al. MRI and quantification of draining lymph node function in inflammatory arthritis. Ann N Y Acad Sci 2007; 1117: 106-23.
15. Lane NE, Yao W, Balooch M, Nalla RK, Balooch G, Habelitz S, et al. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res 2006; 21: 466-76.
16. Maher JR, Berger AJ,. Determination of ideal offset for spatially offset Raman spectroscopy. Appl Spectrosc 2010; 64: 61-5.
17. Maher JR, Takahata M, Awad HA, Berger AJ,. Raman spectroscopy detects deterioration in biomechanical properties of bone in a glucocorticoid-treated mouse model of rheumatoid arthritis. J Biomed Opt 2011; 16: 087012.
18. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R,. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 2010; 25: 1468-86.
19. Reynolds DG, Hock C, Shaikh S, Jacobson J, Zhang X, Rubery PT, et al. Micro-computed tomography prediction of biomechanical strength in murine structural bone grafts. J Biomech 2007; 40: 3178-86.
20. Cowin SC, editor. Bone mechanics handbook. 2nd ed. Boca Raton (FL): CRC Press; 2001.
21. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units: report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987; 2: 595-610.
22. Akkus O, Adar F, Schaffler MB,. Age-related changes in physicochemical properties of mineral crystals are related to impaired mechanical function of cortical bone. Bone 2004; 34: 443-53.
23. van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C,. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 2006; 54: 3104-12.
24. Brodt MD, Ellis CB, Silva MJ,. Growing C57BL/6 mice increase whole bone mechanical properties by increasing geometric and material properties. J Bone Mineral Res 1999; 14: 2159-66.
25. Silva MJ, Brodt MD, Wopenka B, Thomopoulos S, Williams D, Wassen MH, et al. Decreased collagen organization and content are associated with reduced strength of demineralized and intact bone in the SAMP6 mouse. J Bone Miner Res 2006; 21: 78-88.
26. Battaglia TC, Tsou AC, Taylor EA, Mikic B,. Ash content modulation of torsionally derived effective material properties in cortical mouse bone. J Biomech Eng 2003; 125: 615-9.
27. Burstein AH, Zika JM, Heiple KG, Klein L,. Contribution of collagen and mineral to the elastic-plastic properties of bone. J Bone Joint Surg Am 1975; 57: 956-61.
28. Currey JD,. The effect of porosity and mineral content on the Young's modulus of elasticity of compact bone. J Biomech 1988; 21: 131-9.
29. Boskey AL, Wright TM, Blank RD,. Collagen and bone strength. J Bone Miner Res 1999; 14: 330-5.
30. Burr DB,. The contribution of the organic matrix to bone's material properties. Bone 2002; 31: 8-11.
31. Reilly DT, Burstein AH,. The mechanical properties of cortical bone [review]. J Bone Joint Surg Am 1974; 56: 1001-22.
32. Turner CH,. Yield behavior of bovine cancellous bone. J Biomech Eng 1989; 111: 256-60.
33. Bi X, Patil CA, Lynch CC, Pharr GM, Mahadevan-Jansen A, Nyman JS,. Raman and mechanical properties correlate at whole bone- and tissue-levels in a genetic mouse model. J Biomech 2011; 44: 297-303.
34. Paschalis EP, Verdelis K, Doty SB, Boskey AL, Mendelsohn R, Yamauchi M,. Spectroscopic characterization of collagen cross-links in bone. J Bone Miner Res 2001; 16: 1821-8.
35. Paschalis EP, Recker R, DiCarlo E, Doty SB, Atti E, Boskey AL,. Distribution of collagen cross-links in normal human trabecular bone. J Bone Miner Res 2003; 18: 1942-6.
36. Valcourt U, Merle B, Gineyts E, Viguet-Carrin S, Delmas PD, Garnero P,. Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J Biol Chem 2007; 282: 5691-703.
37. Viguet-Carrin S, Roux JP, Arlot ME, Merabet Z, Leeming DJ, Byrjalsen I, et al. Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae. Bone 2006; 39: 1073-9.
38. Viguet-Carrin S, Garnero P, Delmas PD,. The role of collagen in bone strength. Osteoporos Int 2006; 17: 319-36.
39. Paschalis EP, Shane E, Lyritis G, Skarantavos G, Mendelsohn R, Boskey AL,. Bone fragility and collagen cross-links. J Bone Miner Res 2004; 19: 2000-4.
40. Den Uyl D, Bultink IE, Lems WF,. Advances in glucocorticoid-induced osteoporosis. Curr Rheumatol Rep 2011; 13: 233-40.
41. Yao W, Cheng Z, Busse C, Pham A, Nakamura MC, Lane NE,. Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis Rheum 2008; 58: 1674-86.
42. Ohnaka K, Tanabe M, Kawate H, Nawata H, Takayanagi R,. Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts. Biochem Biophys Res Commun 2005; 329: 177-81.
43. Ohnaka K, Taniguchi H, Kawate H, Nawata H, Takayanagi R,. Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis. Biochem Biophys Res Commun 2004; 318: 259-64.
44. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC,. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest 1998; 102: 274-82.
45. Weinstein RS, Wan C, Liu Q, Wang Y, Almeida M, O'Brien CA, et al. Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell 2010; 9: 147-61.
46. Plotkin LI, Manolagas SC, Bellido T,. Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinase-mediated survival: evidence for inside-out signaling leading to anoikis. J Biol Chem 2007; 282: 24120-30.
47. Bonewald LF,. Osteocyte biology: its implications for osteoporosis. J Musculoskelet Neuronal Interact 2004; 4: 101-4.
48. Yao Z, Li P, Zhang Q, Schwarz EM, Keng P, Arbini A, et al. Tumor necrosis factor-α increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J Biol Chem 2006; 281: 11846-55.
49. Weinstein RS,. Glucocorticoid-induced osteoporosis. Rev Endocr Metab Disord 2001; 2: 65-73.
50. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL,. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000; 15: 2-12.
51. Storey JD,. A direct approach to false discovery rates. J R Stat Soc Ser B 2002; 64: 479-98.